| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |